Please select the option that best describes you:

Do you offer adjuvant therapy for localized medullary carcinoma of the ascending colon that is MSI-H?  

Do you use the same high risk factors as adenocarcinoma when deciding on adjuvant treatment for early stage disease?



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at University Of Wisconsin Department Of Medicine
Thank you, Dr. @Anita Turk. I have a similar situa...
Medical Oncologist at St Louis Cancer Care LLP
I have a patient in her late 80s with one positive...
Medical Oncologist at Bon Secours Saint Mary's Hospital
With now available data from the Atomic trial woul...
Sign in or Register to read more